Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 3
1980 1
1982 4
1983 6
1984 5
1985 1
1986 1
1987 2
1988 7
1989 6
1990 9
1991 2
1992 2
1994 4
1995 2
1996 6
1997 2
1998 3
1999 3
2000 6
2001 7
2002 6
2003 15
2004 16
2005 15
2006 19
2007 19
2008 20
2009 13
2010 16
2011 26
2012 17
2013 20
2014 16
2015 26
2016 12
2017 9
2018 12
2019 19
2020 21
2021 23
2022 24
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Results by year

Filters applied: . Clear all
Page 1
Factors Associated With the Development of Bacterial Pneumonia Related to Seasonal Influenza Virus Infection: A Study Using a Large-scale Health Insurance Claim Database.
Shirata M, Ito I, Jo T, Iwao T, Oi I, Hamao N, Nishioka K, Yamana H, Nagase T, Yasunaga H, Hirai T. Shirata M, et al. Among authors: oi i. Open Forum Infect Dis. 2023 Apr 21;10(5):ofad222. doi: 10.1093/ofid/ofad222. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37234515 Free PMC article.
Development and validation of a new scoring system for prognostic prediction of community-acquired pneumonia in older adults.
Shirata M, Ito I, Ishida T, Tachibana H, Tanabe N, Konishi S, Oi I, Hamao N, Nishioka K, Matsumoto H, Yasutomo Y, Kadowaki S, Ohnishi H, Tomioka H, Nishimura T, Hasegawa Y, Nakagawa A, Hirai T. Shirata M, et al. Among authors: oi i. Sci Rep. 2021 Dec 13;11(1):23878. doi: 10.1038/s41598-021-03440-3. Sci Rep. 2021. PMID: 34903833 Free PMC article.
Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.
Nakamura A, Matsumura T, Ogata K, Mori-Yoshimura M, Takeshita E, Kimura K, Kawashima T, Tomo Y, Arahata H, Miyazaki D, Takeshima Y, Takahashi T, Ishigaki K, Kuru S, Wakisaka A, Awano H, Funato M, Sato T, Saito Y, Takada H, Sugie K, Kobayashi M, Ozasa S, Fujii T, Maegaki Y, Oi H, Tachimori H, Komaki H. Nakamura A, et al. Among authors: oi h. Ann Clin Transl Neurol. 2023 Dec;10(12):2360-2372. doi: 10.1002/acn3.51925. Epub 2023 Oct 26. Ann Clin Transl Neurol. 2023. PMID: 37882106 Free PMC article.
Genetically engineered antibody molecules.
Morrison SL, Oi VT. Morrison SL, et al. Among authors: oi vt. Adv Immunol. 1989;44:65-92. doi: 10.1016/s0065-2776(08)60640-9. Adv Immunol. 1989. PMID: 2646862 Review. No abstract available.
Dinitrogen Coordination to a High-Spin Diiron(I/II) Species.
Torres JF, Oi CH, Moseley IP, El-Sakkout N, Knight BJ, Shearer J, García-Serres R, Zadrozny JM, Murray LJ. Torres JF, et al. Among authors: oi ch. Angew Chem Int Ed Engl. 2022 May 23;61(22):e202202329. doi: 10.1002/anie.202202329. Epub 2022 Mar 31. Angew Chem Int Ed Engl. 2022. PMID: 35302701 Free PMC article.
Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis.
Shirata M, Ito I, Tanaka M, Murata K, Murakami K, Ikeda H, Oi I, Hamao N, Nishioka K, Hayashi Y, Nagao M, Hashimoto M, Ito H, Ueno H, Morinobu A, Hirai T. Shirata M, et al. Among authors: oi i. Clin Exp Med. 2023 Dec;23(8):4707-4720. doi: 10.1007/s10238-023-01163-5. Epub 2023 Aug 16. Clin Exp Med. 2023. PMID: 37582911
Humoral immune responses were assessed by quantifying anti-spike IgG antibody titers and the capacity of circulating antibodies to neutralize the ancestral SARS-CoV-2 strain and the Alpha, Delta, and Omicron variants. Vaccine-induced T-cell responses were measured using an …
Humoral immune responses were assessed by quantifying anti-spike IgG antibody titers and the capacity of circulating antibodies to neutraliz …
Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
Inatani M, Orii Y, Iwasaki K, Arimura S, Sunagawa H, Shiokawa M, Inoue K, Sakono T, Sakono T, Kuwamura R, Yoshida A, Oi J, Kuwayama Y, Kano K, Kido N, Matsuyama A, Ozaki M, Abe H, Inoue C, Nakagawa S, Musashi K, Kanamori A, Lee J, Otani S, Aoki R, Tanabe H, Nakakura S, Suzuki K, Sagara T, Saito Y, Sameshima M, Urahashi M, Watanabe-Kitamura F, Inoue T, Kagaya F, Murai Y, Mori S, Ueda K, Kurimoto T, Yamada-Nakanishi Y, Nakamura M, Yamashita T, Ishiyama S, Manabe S, Takaki K, Hayashi K, Ishida A, Tsutsui A, Manabe K, Tanito M. Inatani M, et al. Among authors: oi j. Adv Ther. 2023 Sep;40(9):4074-4092. doi: 10.1007/s12325-023-02589-9. Epub 2023 Jul 15. Adv Ther. 2023. PMID: 37452961 Free PMC article. Clinical Trial.
429 results